Sonic Healthcare (OTCMKTS:SKHHY) was downgraded by analysts at CLSA from an “outperform” rating to an “underperform” rating in a research report issued on Thursday, The Fly reports.
Separately, Jefferies Financial Group raised shares of Sonic Healthcare from a “hold” rating to a “buy” rating and set a $45.75 price objective for the company in a research report on Monday, October 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, Sonic Healthcare currently has a consensus rating of “Hold” and an average price target of $45.75.
OTCMKTS:SKHHY opened at $29.27 on Thursday. The firm has a 50 day simple moving average of $31.09 and a 200-day simple moving average of $30.27. Sonic Healthcare has a 1-year low of $23.32 and a 1-year high of $34.30.
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Imaging, and Other. The Laboratory segment offers pathology and clinical services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium, and Ireland.
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.